AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
ARIPIPRAZOLE in Zimbabwe
10 products registered with MCAZ — 10 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ARIPITAS OD 15 TABLET; ORAL | 2025/13.2.3/6992 | INTAS PHARMACEUTICAL LIMITED | active | 29 Jun 2030 |
| ARIPTAS OD 10 TABLET; ORAL | 2025/13.2.3/6991 | INTAS PHARMACEUTICAL LIMITED | active | 29 Jun 2030 |
| ARIP MT10 TABLET; ORAL | 2023/13.2.3/6515 | TORRENT PHARMACEUTICALS | active | 21 Nov 2028 |
| ARIP MT15 TABLET; ORAL | 2023/13.2.3/6516 | TORRENT PHARMACEUTICALS | active | 21 Nov 2028 |
| ARIPIPRAZOLE TABLET, COATED; ORAL | 2024/13.2.3/6791 | KARLADE GLOBAL DMCC | active | 31 Dec 2027 |
| ARIPIPRAZOLE TABLET, COATED; ORAL | 2024/13.2.3/6792 | KARLADE GLOBAL DMCC | active | 31 Dec 2027 |
| THRYVE 5 TABLET, COATED; ORAL | 2019/13.2.3/5911 | NEW AVAKASH INTERNATIONAL | active | 31 Dec 2027 |
| ARIPRIPAZOLE TABLET, COATED; ORAL | 2024/13.2.3/6790 | KARLADE GLOBAL DMCC | active | 31 Dec 2027 |
| THRYVE 10 TABLET; ORAL | 2019/13.2.3/5914 | NEW AVAKASH INTERNATIONAL | active | 31 Dec 2027 |
| THRYVE 15 TABLET; ORAL | 2019/13.2.3/5915 | NEW AVAKASH INTERNATIONAL | active | 31 Dec 2027 |
ARIPIPRAZOLE — MCAZ Registration Details
MCAZ (Zimbabwe) has 10 registered products containing ARIPIPRAZOLE, of which 10 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track ARIPIPRAZOLE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.